HomeCLSD • NASDAQ
add
Clearside Biomedical Inc
Previous close
$1.31
Day range
$1.30 - $1.34
Year range
$0.65 - $2.12
Market cap
97.90M USD
Avg Volume
212.48K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | 230.00K | 5,650.00% |
Operating expense | 8.44M | 10.91% |
Net income | -11.76M | -26.76% |
Net profit margin | -5.11K | 97.80% |
Earnings per share | -0.17 | -13.33% |
EBITDA | -8.19M | -7.93% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 35.36M | -14.64% |
Total assets | 40.14M | -10.19% |
Total liabilities | 61.95M | 47.52% |
Total equity | -21.81M | — |
Shares outstanding | 69.85M | — |
Price to book | -4.23 | — |
Return on assets | -55.35% | — |
Return on capital | -82.64% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -11.76M | -26.76% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
2011
Headquarters
Website
Employees
30